DEA’s Marijuana Rescheduling Hearing Delayed Until After 2024 Presidential Election
Cannabis stocks took a hit as the Drug Enforcement Administration (DEA) announced that a hearing to consider reclassifying marijuana as a less harmful drug won’t take place until December 2, 2024, after the presidential election.
Stocks Plummet
Following the news of the delayed hearing, cannabis stocks experienced a significant decline. Canopy Growth Corp. (CGC) saw a decrease of approximately 9.5%, while Tilray Brands (TLRY) dropped nearly 6% and Aurora Cannabis (ACB) slid almost 5%. The AdvisorShare Pure U.S. Cannabis ETF (MSOS), the largest exchange-traded fund (ETF) for cannabis stocks, tumbled about 13%.
The Current Classification
For decades, marijuana has been classified as a Schedule I drug under the Controlled Substances Act, placing it in the same category as heroin, LSD, and other substances with a high potential for abuse. This classification has made marijuana illegal under federal law.
On the other hand, Schedule III drugs, such as anabolic steroids, Tylenol with codeine, and ketamine, are considered to have a moderate to low potential for dependence.
Election Impact
The decision to schedule the hearing after the 2024 presidential election holds significant implications as the candidates may have differing approaches to marijuana legalization.
Vice President Kamala Harris has been vocal about her support for marijuana legalization. In March, she called on the Department of Justice to expedite the rescheduling of marijuana after the Department of Health and Human Services recommended doing so last year.
Former President Donald Trump’s stance on cannabis policy has been less clear. However, during his presidency in 2018, he expressed potential support for a bipartisan bill that aimed to end the federal ban on marijuana.
Looking Ahead
The delayed hearing by the DEA means that a resolution on the reclassification of marijuana won’t come until after the 2024 presidential election. This timeline leaves the future of marijuana legalization uncertain, as it will depend on the outcome of the election and the approach taken by the next administration.
Investors in the cannabis industry will need to closely monitor the political landscape and stay informed about the candidates’ positions on marijuana legalization. Any changes in federal regulations could have a significant impact on the profitability and growth potential of cannabis stocks.
It is worth noting that despite the current federal classification of marijuana, many states have already legalized its use for medical and/or recreational purposes. This patchwork of state laws has created a complex legal landscape for cannabis businesses, with federal regulations conflicting with state laws.
As the debate around marijuana legalization continues, it is crucial for investors, industry stakeholders, and consumers to stay informed and engaged in the political process. The outcome of the 2024 presidential election will likely play a significant role in shaping the future of marijuana policy in the United States.
Disclaimer: The information provided in this article is for informational purposes only and should not be construed as legal or investment advice. It is always recommended to consult with a qualified professional before making any investment decisions.
Read the original article on Investopedia.
